Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCorbus Pharmaceuticals Holdings, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Corbus Pharmaceuticals Holdings, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity
    Sep 14, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP) Press Releases
  • Corporate Presentation
    Sep 14, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP) Presentations
  • Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
    Sep 11, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP) Press Releases
  • Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Aug 17, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP) Press Releases
  • Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
    Aug 6, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP) Press Releases
  • Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
    Aug 4, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP) Press Releases
  • Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer
    Jul 28, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP) Press Releases
  • Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
    Jul 6, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP) Press Releases
  • Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers
    May 26, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP) Press Releases
  • Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
    May 21, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$5.38Close ยท Oct 9, 2026